Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Madhukar H. Trivedi - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
1
x
$
30.00
Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach
1
x
$
30.00
Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression
1
x
$
30.00
What Mood Symptoms may be most Difficult to Rate?
1
x
$
30.00
Gregory J. Moore, PhD: Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders
1
x
$
30.00
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
1
x
$
30.00
View Cart
Checkout
Home
andrei-pikalov
“Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Ross A. Baker – Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
$
30.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
